NEWS AND PRESS APPEARANCES

WE ARE ALSO PRESENT IN THE MEDIA

Do you want to keep up to date with the latest information about us and get to know our diverse business? Here you will find our press releases with all the news about MEXACARE. Get a comprehensive overview of our expertise. On this page, you will find current news and articles from media appearances. Are you looking for specific articles, press photos, or an interview appointment? Contact us.

MEXACARE WINS BOOTS

AS A NEW CLIENT.

to be released soon.

MEXACARE DISTRIBUTES 

ONCE AGAIN TO ROSSMANN

The drugstore chain Rossmann awarded the German quality manufacturer MEXACARE the renewed order for the production of digital pregnancy tests of the well-known, own brand „Facelle“.

Just like in the past, MEXACARE has now developed a further test for the drugstore chain’s rapid test portfolio, based on Rossmann’s strict guidelines.

The initial stock was delivered in several truck loads.

As a certified in-vitro diagnostics company that has been audited by the approval authority (notified body) without deviations, MEXACARE is characterized by, among other things, local expertise, German quality, direct access to raw materials such as plasma – which are extremely important for the development and validation of rapid tests – as well as through fast delivery times, our own logistics fleet and absolute transparency in the development, manufacture and distribution of high-quality and proven rapid diagnostics.

MEXACARE is demonstrably in a sustainable position to meet the high quality standards as a leading German manufacturer of in-vitro diagnostics.

In addition to pregnancy tests, MEXACARE has already served other orders from the Rossmann drugstore chain and is now present with another new product in over 2500 branches throughout Germany.

MEXACARE GmbH is already planning further large-scale orders from the food retail sector in order to ensure a standardized, excellent and consistent quality of the quick test to be purchased across the whole of the retail sector.

Mexacare also manufactures well-known products for distribution in pharmacies.

As an excellent quality manufacturer and one of the few companies in the world that has CE certification for the COVID-19 antigen and antibody home test, well-known companies such as Stada, Puren, Actavis, MedVec and Rossmann have been placing their trust in MEXACARE GmbH as a contract manufacturer for years.

“We are very happy about the good and sustainable business relationship as a supplier for Rossmann and so we can prove once again that all the rapid tests we produce meet the high quality standards of well-known, internationally established companies. In addition to the COVID-19 relevant large orders to the government of Austria and Baden-Württemberg, hospital and nursing home chains as well as non-profit organizations, we have now successfully started the parallel production of further rapid tests from our portfolio. This will make a significant contribution to the further growth and expansion of our company ”, says Knut Butzinger, CEO of MEXACARE GmbH.

MEXACARE MASTERS THE IVD

MANUFACTURER AUDIT WITHOUT ANY DEVIATION

In this year’s multi-day audit, MEXACARE once again demonstrated that quality, professionalism and production in Germany pay off.

The highly sensitive development and production processes, the strict qualitative approval regulations, as well as the corporate responsibility of the German diagnostics company were carefully checked by the independent approval body and the audit was successfully passed without any deviations.

Despite an extreme growth phase in 2021, all approval requirements were met in order to guarantee the consistent, high quality as a German manufacturer of rapid diagnostics.

The regulatory hurdles for IVDD Directive (IVDR) will be tightened in 2022, which is why MEXACARE GmbH has already proven in 2021 that it is prepared for the further stricter rules.

read more

CE CERTIFICATION

FOR THE ANTIGEN HOME-TEST

After MEXACARE was the first German company to receive CE certification for the antibody home test in spring 2021, MEXACARE is now the first German ISO-certified manufacturer of in-vitro diagnostics to have another full CE certification for the MEXACARE antigen home test from the notified body CE0483 received.

The full CE certification, with up to 600 pages of documentation, thus replaces the temporary special approval of the BfArM, under which the currently available rapid tests were brought into circulation temporarily (using a comparatively simple and intransparent express procedure) and outside of the regular approval procedure.

With a sensitivity of 99.9% – even with a high Ct value of up to 34 – the home antigen test from the German in-vitro diagnostics manufacturer MEXACARE is extremely sensitive, and thus also the earliest stages of a potential detect infection.

VDGH CLAIMS:

RETHINK THE TEST STRATEGY

Against the background of the current pandemic situation in Germany, the Association of the Diagnostics Industry, VDGH, calls for a realignment of the national test strategy.

Above all, the antibody tests that have long been used in other health systems (e.g. France, Italy, GB, Austria) should play an important role.

With the increasing vaccination coverage of the population, antibody diagnostics are becoming much more important than before.

Antibody tests can help in three important areas:

In demonstrating the effectiveness of the vaccines available!

Here, antibody tests can be used to determine evidence-based knowledge about the effectiveness of the vaccines. In addition, an individual success control, as well as the acquisition of new knowledge in patients with previous illnesses (e.g. immunosuppressed patients) is guaranteed.

read more

MEXACARE TEST CENTERS

OPENED SUCCESSFULLY

The need for rapid tests remains high. In order to be able to meet the great demand, the German diagnostics manufacturer MEXACARE is opening its own test centers.

The first own test center was successfully started in Bad Münstereifel, as the exclusive partner of the City Outlet, in order to reliably test the local retail trade and the population with verifiably 99.9% sensitive tests (even with a Ct value of 34).

With up to 400 tests per day (including symptom query, registration, data collection and actual test execution), the capacities of the MEXACARE rapid test center are well used.

MEXACARE also offers other rapid test centers a 30-day supply of the safe MEXACARE COVID-19 home test antigen without the need for pre-financing.

MEXACARE thus makes a sustainable contribution to fighting pandemics, because responsible testing only makes sense with safe tests in order to get the pandemic under control.

www.schnelltestzentrum-bam.de

STATE GOVERNMENT OF BADEN-WÜRTTEMBERG

TRUSTS IN MEXACARE

There are problems with the delivery of corona rapid tests in Baden-Württemberg. The state government justifies this with nationwide bottlenecks.

With this background, the Heidelberg diagnostics company distinguishes itself as a reliable strategic partner of the state government and currently supplies almost 1 million antigen home tests to the state of Baden-Württemberg.

In direct consultation with the ministry, delivery should take place within 5 working days to up to 350 locations in the state.

read more

BfArM SPECIAL APPROVAL

FOR THE ANTIGEN HOME-TEST

MEXACARE GmbH is the first medium-sized ISO-certified manufacturer of in-vitro diagnostics to receive approvals for Corona (SARS-CoV-2) home tests. After MEXACARE was the first company to receive full CE certification for the MEXACARE IgG / IgM antibody home test from the notified body – CE0483 – the Federal Ministry for Drugs and Medical Devices (BfArM) has now also granted special approval for the MEXACARE CORONA-19 antigen home test.

REPUBLIC OF AUSTRIA

TRUSTS IN MEXACARE

MEXACARE receives the official delivery contract for SARS-Cov-2 (Covid-19) antigen tests for the Republic of Austria.

Another government trusts the quality of the German diagnostics company MEXACARE.

The Republic of Austria convinced the 99.9% sensitivity in the particularly important Ct range between 20-34, validated studies, the fast delivery, the customer service and the years of experience of MEXACARE – in the production, validation and approval of rapid diagnostic preparations.

MEXACARE IN DEN MEDIEN

März, KW 15

MEXACARE is among others. Present in Focus, Süddeutsche Zeitung, Aachener Zeitung, Wallstreet Online and other media.

read more

MEXACARE IN SWR1

INTERVIEW

Self-tests for all – Mexacare from Heidelberg is in the starting blocks. Report by Wolfgang Brauer.

READ ARTICLE

MEXACARE AT THE

PAT KENNY SHOW

Knut Butzinger, founder of Mexacare, joined Pat on the show to talk about the ten-minute anti-gene tests being delivered to the German and Austrian governments.

continue to article

MEXACARE RECEIVES CE APPROVAL

FOR THE IgG/IgM ANTIBODY HOME TEST

MEXACARE GmbH is the first and only German ISO-certified manufacturer of in-vitro diagnostics to receive full approval for the Corona (SARS-CoV-2) antibody home test. MEXACARE is the first German diagnostics company to obtain full CE certification for the MEXACARE IgG/IgM antibody home test from the Notified Body (CE0483)! After MEXACARE had already submitted the necessary technical documentation and lay studies for a full approval procedure for its antibody home test in April 2020, the first approval for the COVID-19 antibody home test has now come.

READ MORE